NNNaoko Arano Nitta

Naoko Arano Nitta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naoko Arano Nitta has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Aki Mitsui

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Hitomi Yoshikawa

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Moegi Komura

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Tadashi Sato

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Yuzo Kodama

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    2 shared publications
  • Eriko Kuwasaki

    Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

    1 shared publication

Latest Publications

  • miR-146a regulates emphysema formation and abnormal inflammation in the lungs of two mouse models

    by Hitomi Yoshikawa, Tadashi Sato, Kimiko Horikoshi, Moegi Komura, Naoko Arano Nitta, Aki Mitsui, Kengo Koike, Yuzo Kodama, Kazuhisa Takahashi

    This study demonstrates that miR-146a expression is upregulated in mouse lungs because of elastase- and CS-induced emphysema and that the inflammatory response by elastase or CS is enhanced in the lungs of miR-146a-KO mice than in those of control mice, resulting in the promotion of emphysema. This is the first study to evaluate the protective role of miR-146a in emphysema formation and the associated abnormal inflammatory response in different in vivo models.


  • Exposure to the heated tobacco product IQOS generates apoptosis-mediated pulmonary emphysema in murine lungs

    by Naoko Arano Nitta, Tadashi Sato, Moegi Komura, Hitomi Yoshikawa, Yohei Suzuki, Aki Mitsui, Eriko Kuwasaki, Fumiyuki Takahashi, Yuzo Kodama, Kuniaki Seyama, et al.

    Pulmonary emphysema is predominantly caused by chronic exposure to cigarette smoke (CS). Novel tobacco substitutes, such as heated tobacco products (HTPs), have emerged as healthier alternatives to cigarettes. IQOS, the most popular HTP in Japan, is advertised as harmless compared with conventional cigarettes. Although some studies have reported its toxicity, few in vivo studies have been conducted. Here, 12-wk-old C57BL6/J male mice were divided into three groups and exposed to air (as control), IQOS aerosol, or CS for 6 mo. After exposure, the weight gain was significantly suppressed in the IQOS and CS groups compared with the control (−4.93 g; IQOS vs. air and −5.504 g; CS vs. air). The serum cotinine level was significantly higher in the IQOS group than in the control group. The neutrophils and lymphocyte count increased in the bronchoalveolar lavage fluid of the IQOS and CS groups compared with those in the control group. Chronic IQOS exposure induced pulmonary emphysema similar to that observed in the CS group. Furthermore, expression levels of the genes involved in the apoptosis-related pathways were significantly upregulated in the lungs of the IQOS-exposed mice. Cytochrome c, cleaved caspase-3, and cleaved poly (ADP-ribose) polymerase-1 were overexpressed in the IQOS group compared with the control. Single-stranded DNA and TdT-mediated dUTP nick-end labeling-positive alveolar septal cell count significantly increased in the IQOS group compared with the control. In conclusion, chronic exposure to IQOS aerosol induces pulmonary emphysema predominantly via apoptosis-related pathways. This suggests that HTPs are not completely safe tobacco products.